ZAQS.ORG

Novo Nordisk faces a defining year in the obesity drug market. It's off to a dramatic start

5 hours ago

How largest health-care education company in U.S. is tackling growing jobs gap

5 hours ago

Novo CEO sees 15 million patient opportunity in Medicare obesity coverage

7 hours ago

Moderna says FDA refuses to review its application for experimental flu shot

1 day ago

CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold

1 day ago

Florida law models what genetic disease testing could be

1 day ago

FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims

1 day ago

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections

2 days ago

Hims & Hers stops offering weight loss pill after threats of legal action

2 days ago

Healthy Returns: Pfizer execs chart out obesity drug strategy

4 days ago

White House launches direct-to-consumer drug site TrumpRx. Here's what to know

6 days ago

Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline

6 days ago

Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar

7 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

8 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook

8 days ago

Merck tops quarterly estimates, posts modest outlook as generic competition looms

8 days ago

Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch

8 days ago

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

12 days ago

As ACA subsidies expire, health costs emerge as top economic worry for voters: survey

12 days ago

Breakthrough drug helps 11-year-old battle rare neurological gene mutation

12 days ago

Healthy Returns: 15 drugs added to Medicare price negotiations

12 days ago

Danaher stock fails to rise on solid earnings — leading us to question what's next

14 days ago

UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround

14 days ago

Next up in weight loss drugs: More pills, easier access and drug combinations

15 days ago

Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s

19 days ago

Amazon launches AI health-care tool for One Medical members

21 days ago

OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion

21 days ago

Another alliance of health care and AI signals why pharma stocks could be back

21 days ago

Drug pricing, patent losses, deals: What pharma execs see ahead in the industry

22 days ago

Novo Nordisk shares rise after Wegovy obesity pill has 'solid' start to launch

22 days ago

Keeping U.S. biotech ahead of China's could help rare disease patients, experts say

26 days ago

Healthy Returns: Novo CEO on GLP-1 pricing, and more insights from the JPM conference

26 days ago

OpenAI acquires health-care technology startup Torch for $60 million: Source

28 days ago

Thanks for your support, here's how to connect with us

30 days ago